Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.

Bharat Biotech, known for Covaxin, is establishing an Ella Foods processing unit in Kochi’s Angamaly KSIDC park. The unit will produce health-focused food products for Indian and export markets.

Rs 31,429 crore from the Invest Kerala Global Summit have begun construction, creating 40,439 jobs. Key investments include ...

Bharat Biotech and GSK to reduce price of malaria vaccine for children to less than USD 5 by 2028.

India Business News: HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s first malaria.

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by 2028. This price cut, exceeding 50%, is part of their commitment to Gavi's ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British drugmaker GSK, the company has invested $200 million in building ...

Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world’s first ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices.

GSK and Bharat Biotech collaborate to reduce malaria vaccine price, enhance production, and supply to Gavi by 2028.

GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its Shigella vaccine candidate to Bharat Biotech.